Dr. Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Tuesday, November 08, 2022 to consider and approve the Un-Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended September 30, 2022.
The above information is a part of company’s filings submitted to BSE.